NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. (NAMS)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -7.368 | -10.94 | -9.847 | -2.244 |
| Net Profit Margin | -1,612.27 | -233,656.25 | -20,601.149 | -91.256 |
| Debt to Asset Ratio | 9.202 | 11.16 | 7.421 | 4.492 |
| Cash Ratio | 678.731 | 571.184 | 923.955 | 1,544.325 |
| Quick Ratio | 976.022 | 787.648 | 1,256.741 | 2,108.485 |
| Current Ratio | 976.022 | 787.648 | 1,256.741 | 2,108.485 |